These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 9380020)

  • 21. Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.
    Davenport AP; Kuc RE; Ashby MJ; Patt WC; Doherty AM
    Br J Pharmacol; 1998 Jan; 123(2):223-30. PubMed ID: 9489609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelin-1 (ET-1)-induced contraction in rat isolated trachea: involvement of ETA and ETB receptors and multiple signal transduction systems.
    Henry PJ
    Br J Pharmacol; 1993 Sep; 110(1):435-41. PubMed ID: 8220905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High affinity interaction of endothelin-3 with recombinant ETA receptors.
    Desmarets J; Frelin C
    Biochem Biophys Res Commun; 1999 Mar; 256(2):357-60. PubMed ID: 10079188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predominance of endothelinA (ETA) receptors in ovine airway smooth muscle and their mediation of ET-1-induced contraction.
    Goldie RG; Grayson PS; Knott PG; Self GJ; Henry PJ
    Br J Pharmacol; 1994 Jul; 112(3):749-56. PubMed ID: 7921598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of endothelin receptor subtypes in rat retina using subtype-selective ligands.
    de Juan JA; Moya FJ; Fernandez-Cruz A; Fernandez-Durango R
    Brain Res; 1995 Aug; 690(1):25-33. PubMed ID: 7496803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding characteristics of [125I]TTA 386, ETA-selective antagonist.
    Pullen M; Brown G; Nambi P
    Neuropeptides; 1997 Aug; 31(4):345-9. PubMed ID: 9308022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding and functional properties of endothelin receptor subtypes in the human prostate.
    Kobayashi S; Tang R; Wang B; Opgenorth T; Langenstroer P; Shapiro E; Lepor H
    Mol Pharmacol; 1994 Feb; 45(2):306-11. PubMed ID: 8114678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The unusual binding properties of the endothelin receptor antagonist CGS 27830 distinguishes receptor/agonist interactions.
    Chin MH; Cioffi CL; Garay M; Neale RF; Shetty SS; DelGrande D; Mugrage B; Sills MA; Lipson KE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):74-83. PubMed ID: 8558459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and function of putative ETB receptor subtypes in the dog kidney.
    Brooks DP; DePalma PD; Pullen M; Gellai M; Nambi P
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S322-5. PubMed ID: 8587403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of peptide and nonpeptide antagonists in human kidney.
    Kuc RE; Karet FE; Davenport AP
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S373-5. PubMed ID: 8587419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of regional differences in ETA and ETB receptor subtype proportions on endothelin-1-induced contractions in porcine isolated trachea and bronchus.
    Goldie RG; D'Aprile AC; Cvetkovski R; Rigby PJ; Henry PJ
    Br J Pharmacol; 1996 Feb; 117(4):736-42. PubMed ID: 8646422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human placental membranes contain predominantly ETB receptors.
    Buchan KW; Sumner MJ; Watts IS
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S136-9. PubMed ID: 7509925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi.
    Fukuroda T; Ozaki S; Ihara M; Ishikawa K; Yano M; Miyauchi T; Ishikawa S; Onizuka M; Goto K; Nishikibe M
    Br J Pharmacol; 1996 Mar; 117(6):995-9. PubMed ID: 8882588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of endothelin receptor subtypes in rat ciliary body using subtype-selective ligands.
    Ripodas A; De Juan JA; Moya FJ; Fernandez-Cruz A; Fernandez-Durango R
    Exp Eye Res; 1998 Jan; 66(1):69-79. PubMed ID: 9533832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin binding to NG108-15 cells: evidence for conventional ETA and ETB receptor subtypes and super-high affinity binding components.
    Angelova K; Ergul A; Narayan P; Puett D
    Cell Mol Biol (Noisy-le-grand); 1996 Dec; 42(8):1243-57. PubMed ID: 8997527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A reversible radioligand specific for the ETB receptor: [125I]Tyr13-Suc-[Glu9,Ala11,15]-endothelin-1(8- 21), [125I]IRL 1620.
    Watakabe T; Urade Y; Takai M; Umemura I; Okada T
    Biochem Biophys Res Commun; 1992 Jun; 185(3):867-73. PubMed ID: 1320877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of 125I-endothelin-1 and 125I-endothelin-3 in rabbit saphenous vein: evidence for an atypical ET binding component.
    Liu EC; Monshizadegan H; Chao CC; Lynch J; Fisher SM; Rose PM; Webb ML
    J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S132-5. PubMed ID: 7509924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dipeptide sulfonamides as endothelin ETA/ETB receptor antagonists.
    Ksander GM; Shetty SS; DelGrande D; Balwierczak JL; Bruseo CW; Savage P; deJesus R; Yuan A; Webb RL; Jeng AY
    Can J Physiol Pharmacol; 2002 May; 80(5):464-9. PubMed ID: 12056554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242.
    Bacon CR; Morrison JJ; O'Reilly G; Cameron IT; Davenport AP
    J Endocrinol; 1995 Jan; 144(1):127-34. PubMed ID: 7891013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney.
    Karet FE; Kuc RE; Davenport AP
    Kidney Int; 1993 Jul; 44(1):36-42. PubMed ID: 8355464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.